Stéphane Courby

Therapeutic impact and diagnostic performance of multiplex PCR in patients with malignancies and suspected sepsis

Danièle Maubon, Rébecca Hamidfar-Roy, Stéphane Courby et al. · Journal of Infection · 2010 · 46 citations

Medicine, Molecular Medicine, Oncology +16

Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS

Roch Houot, Steven Le Gouill, Christiane Mounier et al. · Annals of Oncology · 2011 · 44 citations · Full text

Medicine, Hematology, Oncology +14

A phase 2 study of momelotinib, a potent JAK1 and JAK2 inhibitor, in patients with polycythemia vera or essential thrombocythemia

Srđan Verstovšek, Stéphane Courby, Martin Grießhammer et al. · Leukemia Research · 2017 · 41 citations · Full text

Medicine, Hematology, Pharmacology +8

Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome

Marlijn Hoeks, Timothy Bagguley, Corine van Marrewijk et al. · Leukemia · 2020 · 28 citations · Full text

Medicine, Hematology, Iron Metabolism Disorders +14

<i>Treatment-Free Remissions in Newly Diagnosed CP CML Patients Treated with the Combination of Nilotinib + Pegylated Interferon Alpha 2a Versus Nilotinib Alone in the National Phase III Petals Trial</i>

Franck E. Nicolini, Gabriel Étienne, Françoise Huguet et al. · Blood · 2021 · 16 citations

Pharmacy, Pharmacology, Pharmacotherapy +7